Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/9/25 19:13 | 5/2/25 | ALMS | Health | Drug | Pharmaceutical Preparations | Akkaraju Srinivas | CA | D | 8 | P.am | 35,547 | 11.29 | 0 | 3,148 | 121 | 5,757 | I | |||||||||||||||
11/25/25 16:02 | 11/21/25 | ALMS | Health | Drug | Pharmaceutical Preparations | Foresite Capital Management VI LLC | CA | T | 3 | P.m | 3,830 | 6.13 | 0 | 625 | 4 | 15,778 | I | |||||||||||||||
11/25/25 16:02 | 11/21/25 | ALMS | Health | Drug | Pharmaceutical Preparations | Tananbaum James B. | CA | DT | 3 | P.m | 3,830 | 6.13 | 0 | 625 | 4 | 15,778 | I | |||||||||||||||
11/25/25 16:01 | 11/21/25 | ALMS | Health | Drug | Pharmaceutical Preparations | Foresite Labs, LLC | CA | T | 3 | P.m | 3,830 | 6.13 | 0 | 625 | 4 | 15,778 | I | |||||||||||||||
4/3/25 18:05 | 4/1/25 | ALMS | Health | Drug | Pharmaceutical Preparations | Colowick Alan | MA | D | 1 | P.m | 130 | 7.04 | 0 | 18 | 18 | I | ||||||||||||||||
4/3/25 18:05 | 4/1/25 | ALMS | Health | Drug | Pharmaceutical Preparations | Babler Martin | CA | DO | P,CEO,CB | 1 | P | 101 | 6.44 | 0 | 16 | 17 | 106 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |